Top Articles - Finance

When it comes to investing, many people focus their attention solely on finding

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

the "perfect" strategy. What many people fail to recognize, however, is the fac

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

that all forms of investment markets have "seasons" just like the very predicta

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ble weather patterns of spring, summer, fall and winter.

For example, it is fai

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ly well-known that election year stock markets perform very well. If we step ba

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ck, and analyze the performance of the stock market through out its documented h

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

story, we will see a very predictable pattern of performance.

For example, year

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

s ending with 0 through 5 are poorly performing or negative stock market years.

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

Years ending with 6 are generally transition years, with years 7 through 9 being

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

strong to extremely strong. There are, of course, other factors affecting inve

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

tment seasons, such as interest-rate cycle and peak spending cycles, and there a

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

e no guarantees that any particular year will achieve a specific performance tar

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

get. However, rather than simply looking for a strategy (which obviously would

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ave worked for the author during an appropriate cycle), it is important to match

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

strategy with the broad trends.

While it is obviously no guarantee of success,

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

your odds will increase that a long stock strategy will be successful in the las

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

t part of the decade, while selling options or purchasing money market instrumen

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

s may be a better strategy for the early part of a decade.

I have found this ov

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

er the years to be the most effective way of managing the markets. Regardless,

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

lways keep in mind the protection of your capital, and always invest accordingly

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/101471/toparticles-Making-Big-Money-By-Looking-At-The-Seasons-Of-Investment.html">Making Big Money By Looking At The Seasons Of Investment</a>

BB link (for phorums):
[url=http://www.toparticles.org.ua/article/101471/toparticles-Making-Big-Money-By-Looking-At-The-Seasons-Of-Investment.html]Making Big Money By Looking At The Seasons Of Investment[/url]

Many organizations have digitized humans – aka carbon-based units - out of existence in their customer service operations. It is time to bring the human back into the process.

This article aims to highlight the areas a web designer should think about and incorporate into their design for search engine effectiveness

Tags

Links

Top Articles - Making Big Money By Looking At The Seasons Of Investment

Related Articles: